BR0100379A - Therapeutic use of the synthetic peptide klklllllklk-nh2 - Google Patents

Therapeutic use of the synthetic peptide klklllllklk-nh2

Info

Publication number
BR0100379A
BR0100379A BR0100379A BR0100379A BR0100379A BR 0100379 A BR0100379 A BR 0100379A BR 0100379 A BR0100379 A BR 0100379A BR 0100379 A BR0100379 A BR 0100379A BR 0100379 A BR0100379 A BR 0100379A
Authority
BR
Brazil
Prior art keywords
therapeutic use
synthetic peptide
peptide klklllllklk
klklllllklk
gram
Prior art date
Application number
BR0100379A
Other languages
Portuguese (pt)
Inventor
Salvatore Giovanni De Simone
Andre Luiz Almeida De Souza
Original Assignee
Fundacao Oswaldo Cruz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fundacao Oswaldo Cruz filed Critical Fundacao Oswaldo Cruz
Priority to BR0100379A priority Critical patent/BR0100379A/en
Publication of BR0100379A publication Critical patent/BR0100379A/en

Links

Abstract

"USO TERAPêUTICO DO PEPTìDEO SINTéTICO KLKLLLLLKLK-NH~ 2~". A presente invenção se refere ao uso terapêutico do peptídeo sintético KLKLLLLLKLK-NH~ 2~ contra infecções causadas por bactérias Gram-negativas do gênero Neisseria. A presente invenção demonstra por métodos bioquímicos e celulares a atividade bactericida do peptídeo catiónico KLKLLLLLKLK-NH~ 2~ para a bactéria Gram-negativa N. meningitidis dos sorogrupos A, B e C."THERAPEUTIC USE OF THE SYNTHETIC PEPTIDE KLKLLLLLKLK-NH ~ 2 ~". The present invention relates to the therapeutic use of the synthetic peptide KLKLLLLLKLK-NH ~ 2 ~ against infections caused by Gram-negative bacteria of the Neisseria genus. The present invention demonstrates by biochemical and cellular methods the bactericidal activity of the cationic peptide KLKLLLLLKLK-NH ~ 2 ~ for Gram-negative bacteria N. meningitidis from serogroups A, B and C.

BR0100379A 2001-02-07 2001-02-07 Therapeutic use of the synthetic peptide klklllllklk-nh2 BR0100379A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BR0100379A BR0100379A (en) 2001-02-07 2001-02-07 Therapeutic use of the synthetic peptide klklllllklk-nh2

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR0100379A BR0100379A (en) 2001-02-07 2001-02-07 Therapeutic use of the synthetic peptide klklllllklk-nh2

Publications (1)

Publication Number Publication Date
BR0100379A true BR0100379A (en) 2002-10-15

Family

ID=3946613

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0100379A BR0100379A (en) 2001-02-07 2001-02-07 Therapeutic use of the synthetic peptide klklllllklk-nh2

Country Status (1)

Country Link
BR (1) BR0100379A (en)

Similar Documents

Publication Publication Date Title
BR0112928A (en) Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis
SE0102327D0 (en) A novel engineered superantigen for human therapy
NO20052787D0 (en) N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobial agents
BRPI0608690B8 (en) use of an antimicrobial composition
NO20062918L (en) Use of antibiotics as vaccine adjuvants
BR0214705A (en) Composition, use, method for prevention or treatment of neurodegenerative disease, and kit
DOP2002000429A (en) IMIDAZOTRIAZINAS
BR0012674A (en) Preserved pharmaceutical formulations
ITMI20041550A1 (en) USE OF PROBIOTIC BACTERIA FOR THE PREPARATION OF TOPICAL COMPOSITIONS FOR THE PROTECTION OF THE EPIDERMIS
MXPA05009352A (en) Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections.
EA200600280A1 (en) COMPOSITIONS BASED ON DERIVATIVES OF LIPOPEPTID ANTIBIOTICS AND METHODS OF THEIR APPLICATION
SE0201544D0 (en) Novel compounds and thier use
NO20052788L (en) N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobial agents
AP2003002942A0 (en) New derivatives of oxazolidinones as bacterial agents
BRPI0417858A (en) compound, pharmaceutical composition, and use of a pharmaceutical composition
WO2006108681A3 (en) Substances and pharmaceutical compositions for the inhibition of glyoxalases and their use against bacteria
BRPI0411534A (en) lincomycin derivatives with antimicrobial activity
NO20044549L (en) Bis-cyclic 6-alkalidene penes as beta-lactamase inhibitors
BRPI0406824A (en) Antibacterial indolonaoxazoldinones, intermediates for their preparation and pharmaceutical compositions containing them
UY28542A1 (en) ANTIBACTERIAL MACROCYCLIC AMIDES
BR0309878A (en) Heterotricyclyl-6-alkylidene penenes as beta-lactamase inhibitors
BR0313725A (en) lincomycin derivatives that have antibacterial activity
AR029544A1 (en) COMPOSITIONS AND METHODS TO TREAT BACTERIAL INFECTIONS
BRPI0519752A2 (en) peptide compounds
BR0100379A (en) Therapeutic use of the synthetic peptide klklllllklk-nh2

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: CONFORME ARTIGO 10O DA RESOLUCAO 124/06, CABE SER ARQUIVADO REFERENTE AO NAO RECOLHIMENTO DA 8A ANUIDADE.

B08G Application fees: restoration
B07D Technical examination (opinion) related to article 229 of industrial property law
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 15A ANUIDADE.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2363 DE 19-04-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.